Xiaoyang Li

17PUBLICATIONS
10CO-AUTHORS
Proteins and peptidesBiologically active moleculesBiomolecular modelling and designHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 23, 2026
Design, Synthesis, and Anti-Inflammatory Activity Evaluation of Novel thieno[2,3-d]Pyrimidin-4(3H)-One-Based NLRP3 Inflammasome Inhibitors.

|Nov 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein Degraders.

Simin Sun, Kairui Yue, Enqiang Liu

|Apr 07, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases.

Kairui Yue, Simin Sun, Zequn Yin

|Jun 26, 2024
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax.

Wanting Hao, Leyan Wang, Tongqiang Xu

|Apr 26, 2024
An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators.

Wanting Hao, Dongdong Luo, Yuqi Jiang

|Sep 11, 2023
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis.

Zhuoyue Li, Yiming Chen, Xiaolin Jiang

Pageof 3

Frequent Collaborators

7 joint publications

C James Chou

7 joint publications

Yuqi Jiang

3 joint publications

Yingjie Zhang

2 joint publications

Shengbiao Wan